food and drug administration

GLP-1 Weight Loss Drugs Are Getting a Major Upgrade

GLP-1 Weight Loss Drugs Are Getting a Major Upgrade After New FDA Approval

Both Novo Nordisk’s and competitor Eli Lilly’s injectable GLP-1 drugs, Wegovy and Zepbound, have helped transform obesity treatment around the world, and for the 100 million people in the U.S. impacted by the disease, according to NPR. But Eli Lilly’s oral drug orforglipron is still awaiting approval, with a decision expected by spring.

ConsumerAffairs · 13h

FDA approves a pill version of the weight-loss drug Wegovy

CBS News - Video on MSN · 1h

FDA approves weight loss drug in daily pill form

30mon MSN

Rising prices and weight-loss drugs are changing the way we eat — and food companies are racing to keep up

A strained economy, the growing number of people on weight-loss drugs and changes to government food-assistance programs are some of the looming challenges for food producers in the new year. Makers ...

FDA Officially Confirms Kava is a Food Under Federal Law

After Reviewing Historical Use and Modern Safety Evidence, Officially Confirms Kava is a Food Under Federal Law ...

2don MSN

Accelerated cancer drug approvals yield modest survival gains at significant Medicare cost

Early access to new cancer drugs, granted accelerated approval by the U.S. Food and Drug Administration (FDA), has provided ...

ConsumerAffairs

Nearly 3,000 plaintiffs sue over GLP-1 drug side effects

Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through ...

1don MSN

Christmas Food Recalls: Complete List of Warnings Issued

Numerous recalls have been issued due to potential damage, foodborne illness, contamination and undeclared food allergens.

1don MSN

The FDA Often Doesn’t Test Generic Drugs for Quality Concerns, So ProPublica Did

Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results